Skip to content

Cumberland Pharmaceuticals CPIX Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Baxter International logo
Baxter InternationalBAX
PTH
Pelthos Therapeutics Inc.PTHS
RFL
Rafael Holdings, Inc.RFL
Opko Health logo
Opko HealthOPK

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
Cumberland Pharmaceuticals (CPIX) reported amortization of capitalized software and acquired intangible assets of $1.25M in Q1 2026.
How has Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets increased by 24.2% year-over-year, from $1.01M to $1.25M.
What is the long-term trend for Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a -2.0% compound annual growth rate (CAGR), from $4.37M to $4.03M.